Volume 39, Issue 1, Pages (July 2013)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 34, Issue 3, Pages (March 2011)
Volume 28, Issue 2, Pages (February 2008)
The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles  Kathryn A. Pape, Drew M. Catron,
Volume 31, Issue 2, Pages (August 2009)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 45, Issue 1, Pages (July 2016)
Volume 11, Issue 12, Pages (June 2015)
Volume 36, Issue 5, Pages (May 2012)
Volume 29, Issue 6, Pages (December 2008)
Volume 30, Issue 4, Pages (April 2009)
Volume 38, Issue 3, Pages (March 2013)
Volume 29, Issue 2, Pages (August 2008)
Volume 42, Issue 3, Pages (March 2015)
Volume 31, Issue 1, Pages (July 2009)
Volume 24, Issue 3, Pages (March 2006)
Volume 36, Issue 5, Pages (May 2012)
Volume 25, Issue 3, Pages (September 2006)
Volume 25, Issue 4, Pages (October 2006)
Volume 21, Issue 3, Pages (September 2004)
Volume 33, Issue 1, Pages (July 2010)
Volume 34, Issue 1, Pages (January 2011)
Volume 31, Issue 2, Pages (August 2009)
Volume 34, Issue 5, Pages (May 2011)
Volume 28, Issue 6, Pages (June 2008)
Volume 29, Issue 1, Pages (July 2008)
Volume 17, Issue 3, Pages (October 2016)
Volume 36, Issue 3, Pages (March 2012)
Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4  James Badger Wing, Wataru.
Volume 48, Issue 4, Pages e4 (April 2018)
Novel Role of the Ras Cascade in Memory B Cell Response
Plasma Cells for Hire: Prior Experience Required
Role of B cells in TH cell responses in a mouse model of asthma
Volume 29, Issue 6, Pages (December 2008)
B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells  Wei Luo, Florian.
Volume 36, Issue 2, Pages (February 2012)
Volume 28, Issue 5, Pages (May 2008)
Volume 29, Issue 1, Pages (July 2008)
Volume 28, Issue 4, Pages (April 2008)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
Volume 28, Issue 4, Pages (April 2008)
Volume 34, Issue 3, Pages (March 2011)
Volume 38, Issue 3, Pages (March 2013)
Volume 29, Issue 1, Pages (July 2008)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 41, Issue 1, Pages (July 2014)
Volume 29, Issue 4, Pages (October 2008)
Volume 35, Issue 2, Pages (August 2011)
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin  Rajesh.
Volume 38, Issue 3, Pages (March 2013)
Volume 30, Issue 6, Pages (June 2009)
Volume 17, Issue 3, Pages (September 2002)
Volume 26, Issue 4, Pages (April 2007)
Volume 12, Issue 2, Pages (July 2015)
Volume 32, Issue 1, Pages (January 2010)
Volume 39, Issue 3, Pages (August 2010)
Volume 30, Issue 4, Pages (April 2009)
Volume 28, Issue 5, Pages (May 2008)
Volume 35, Issue 4, Pages (October 2011)
Volume 22, Issue 8, Pages (February 2018)
Yunqi Wang, Maureen A. Su, Yisong Y. Wan  Immunity 
Volume 27, Issue 4, Pages (October 2007)
Volume 25, Issue 12, Pages e5 (December 2018)
Volume 30, Issue 5, Pages (May 2009)
Volume 31, Issue 6, Pages (December 2009)
Volume 31, Issue 5, Pages (November 2009)
The Kinases MEKK2 and MEKK3 Regulate Transforming Growth Factor-β-Mediated Helper T Cell Differentiation  Xing Chang, Fang Liu, Xiaofang Wang, Aiping.
Volume 33, Issue 2, Pages (August 2010)
Volume 25, Issue 4, Pages (October 2006)
Presentation transcript:

Volume 39, Issue 1, Pages 136-147 (July 2013) Repression of the Transcription Factor Bach2 Contributes to Predisposition of IgG1 Memory B Cells toward Plasma Cell Differentiation  Kohei Kometani, Rinako Nakagawa, Ryo Shinnakasu, Tomohiro Kaji, Andrei Rybouchkin, Saya Moriyama, Koji Furukawa, Haruhiko Koseki, Toshitada Takemori, Tomohiro Kurosaki  Immunity  Volume 39, Issue 1, Pages 136-147 (July 2013) DOI: 10.1016/j.immuni.2013.06.011 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Secondary High-Affinity IgG1 Responses Are Derived Mainly from IgG1 Memory B Cells Cγ1-cre gene-targeted mice (control) or Cγ1-cre × iDTR (iDTR; IgG1) mice were immunized with NP-CGG in alum. After 56 days, diphtheria toxin (DT) was injected intraperitoneally (i.p.) for 3 consecutive days. Two days after the last injection, splenocytes were prepared from each mouse strain. (A and B) The percentage of NP-specific IgG1 memory B cells (NP+IgG1+CD38+) in the spleen (A) and NP-specific IgM B cells (NP+IgM+) (B) were measured by flow cytometry. Numbers in each profile indicate the percentage of the gated population. Circles in the right hand plots indicate data from individual mice, and the bar indicates the mean. (C) Serum of each mouse was collected at the indicated time points. Soluble NP-CGG was injected i.p. at day 60 after the primary immunization. Sera were collected at 5 days and 7 days after the rechallenge. Anti-NP high-affinity IgG1 antibodies in sera were measured by ELISA. NP-specific IgG1+CD38+ wild-type memory B cells were collected from NP-CGG in alum-immunized C57BL/6 mice and transferred to DT-treated iDTR; IgG1 mice at day 59. On the next day, recipient mice were boosted with soluble NP-CGG and anti-NP IgG1 titer was determined. Each group consists of more than three mice and representative data of two independent experiments are shown. Data represent the mean ± SD. ∗p < 0.05. See also Figure S1. Immunity 2013 39, 136-147DOI: (10.1016/j.immuni.2013.06.011) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 IgG1 Memory B Cells Have a High Propensity to Differentiate into Plasma Cells (A) Schematic illustration of the transfer experiment. (B) Expression of the indicated molecules was analyzed by flow cytometry. Blue lines indicate the expression by mature follicular NP+CD38+ IgM naive B cells collected from B1-8hi gene-targeted mice. Red lines represent the expression in NP+CD38+ IgG1 memory B cells generated from B1-8hi B cells. (C–E) IgM naive or IgG1 memory B cells were transferred to CGG in alum-primed B6 recipients. On the next day, soluble NP-CGG was administrated i.p. Four days after the rechallenge, spleen cells were analyzed by flow cytometry. (C) CD45.1+ donor cell numbers in spleen were calculated. (D) The percentage of germinal center B cells (Fas+GL7+) among donor cells was determined. Representative flow cytometric data is shown. Numbers indicate the percentage of cells within the gate. (E) Plasma cells derived from donor cells were analyzed by flow cytometry and their percentage is plotted on the right. Flow cytometric data are representative of at least three experiments. Bar graph represents the mean ± SD (n = 3–5). ∗∗p < 0.01, ∗p < 0.05. See also Figure S2. Immunity 2013 39, 136-147DOI: (10.1016/j.immuni.2013.06.011) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 IgG1 Naive B Cells Differentiate in a Similar Fashion to IgM Naive B Cells (A) Schematic illustration of the experimental protocol. (B) Cell surface expression on mature follicular NP+CD38+ IgM naive B cells from B1-8hi gene-targeted mice (blue line) or mature follicular NP+CD38+ IgG1 naive B cells from chimeric mice derived from IgG1-ES NTB2 (red line) was analyzed by flow cytometry. Gray histogram represents the unstained control. (C–E) Mature follicular type cells of IgM naive B cells from B1-8hi gene-targeted mice or IgG1 naive B cells from chimeric mice were sorted and transferred to CGG in alum-primed CD45.1 C57BL/6 mice. NIP-CGG or NP-CGG in PBS was injected i.p. on the next day. Four days later, donor cells were analyzed by flow cytometry. Analysis was carried out as described in the Figure 2 legend. Bar graph represents the mean ± SD (n = 3–5). See also Figure S3. Immunity 2013 39, 136-147DOI: (10.1016/j.immuni.2013.06.011) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Antigen Experience Affects Differentiation Activity of IgG1 B Cells (A) Schematic illustration for the generation of antigen-experienced NP+IgG1+ memory B cells and the transfer experiment. (B) B cells collected from mature follicular naive IgG1 B1-8g1 B cells were labeled with CFSE and transferred to CD45.1 C57BL/6 mice. The mice were immunized with NP-CGG in alum i.p. or not. The donor cells were analyzed for the expression of CFSE, CD38, and IgG1 by flow cytometry 20 days later. Gray histogram represents CFSE-unlabeled recipient B cells. Data are representative of two independent experiments. (C) An antigen-experienced NP+IgG1+ memory or parental NP+IgG1+ naive B cells were purified and transferred to CGG in alum-primed CD45.1 C57BL/6 mice, and differentiation ability was assessed by flow cytometry 4 days later after soluble NP-CGG rechallenge as described in the Figure 2 legend. (D) The amount of each mRNA in NP+IgG1+ naive B cells and antigen-experienced NP+IgG1+ memory B cells was measured by qRT-PCR. Data are representative of at least two independent experiments. Bar graph represents the mean ± SD (n = 3–5). ∗∗p < 0.01, ∗p < 0.05. Immunity 2013 39, 136-147DOI: (10.1016/j.immuni.2013.06.011) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 Expression of Bach2 Is Reduced in IgG1 Memory B Cells (A and B) Mature follicular naive NP+IgM+ B cells were sorted from B1-8hi mice. NP+CD38+B1-8hi IgG1 memory B cells were isolated as shown in Figure 2A. The amount of each mRNA in these cells was measured by qRT-PCR. The data were normalized to the amount of Gapdh. As a control, CD138+ plasma cells were sorted from splenocytes of NP-CGG in alum-immunized C57BL/6 mice. Bar graph represents the mean ± SD. The data are representative of at least three independent experiments. (C) The amount of Pax5 or Bach2 protein was measured by intracellular flow cytometric analysis. Mature follicular naive NP+IgM+ B cells were prepared from B1-8hi mice. NP+CD38+B1-8hi IgG1 memory B cells were prepared as Figure 2A. Then, these B cells were fixed and permeabilized with paraformaldehyde followed by staining with Pax5 antibody or Bach2 antibody. CD3+ T cells were used as a negative control for Pax5. Spleen B cells from Bach2-deficient mice (Bach2f/f × Cd79a-creKI/wt) were used as a negative control for Bach2. The numbers in each profile indicate geometric mean fluorescence intensity (gMFI) of each population. The data are representative of at least three independent experiments. ∗∗p < 0.01. See also Figures S4 and S5. Immunity 2013 39, 136-147DOI: (10.1016/j.immuni.2013.06.011) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 Reduced Expression of Bach2 Facilitates Plasma Cell Differentiation (A) Prestimulated (see Experimental Procedures) B1-8hi IgM B cells were transduced with retroviruses carrying gene silencing constructs for Bach2, Pax5, or empty vector, and further cultured for another 2 days. The transduced GFP+ cells were sorted and gene silencing efficiency was evaluated by qRT-PCR. Bar graph represents the mean ± SD (n = 3). (B) B1-8hi IgM B cells transduced with the indicated retroviruses were transferred to naive C57BL/6 mice followed by immunization with NP-CGG in alum. After 4 days, the donor cells in the spleen gated on GFP+ cells were analyzed for the expression of CD138 and B220 by flow cytometry. The bar in the graph indicates the mean ratio. (C and D) Antigen-experienced NP+CD38+IgG1+ memory B cells from Bach2+/+ × ERT2-creKI/wt × B1-8hi or Bach2f/+ × ERT2-creKI/wt × B1-8hi mice were generated as illustrated in Figure 2A. Mice were treated with 2 mg tamoxifen by p.o. for 3 consecutive days. At 2 days after last administration, the cells were collected from spleen cells and used for the experiments. (C) NP+CD38+ IgG1 memory B cells from Bach2+/+ × ERT2-creKI/wt × B1-8hi or Bach2f/+ × ERT2-creKI/wt × B1-8hi mice were analyzed for measuring the expression of Bach2 by intracellular flow cytometric analysis as described in Figure 5C legend. (D) The above IgG1 memory B cells were transferred to CGG in alum-primed C57BL/6 recipients. On the next day, soluble NP-CGG was administrated i.p. At 4 days after the rechallenge, spleen cells were analyzed by flow cytometry as described in Figure 2 legend. The data represent three independent experiments. Bar graph represents the mean ± SD (n = 3–5). ∗∗p < 0.01, ∗p < 0.05. Immunity 2013 39, 136-147DOI: (10.1016/j.immuni.2013.06.011) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 Bach2 Repression Was Suppressed by Rapamycin (A and C) Purified C57BL/6 spleen B cells were treated with each inhibitor (shown on x axis) for 60 min: mTOR, Rapamycin (20 nM); ERK, PD98059 (50 μM); JNK, SP600125 (10 μM); p38, SB203580 (10 μM); NF-κB, IKK inhibitor (10 μM); AKT, API-2 (20 μM); or Foxo1, AS1842856 (1 μM). These cells were further cultured with CD40 antibody (2 μg/ml), IL-4 (10 ng/ml), and IgM antibody (1 μg/ml) for 6 or 24 hr in the presence of each inhibitor. The amount of Bach2 mRNA in these cells was measured by qRT-PCR. The data were normalized to the amount of Gapdh. The phosphorylation status of S6K, AKT (Ser473), and Foxo1 (Ser256) in the absence of inhibitors was analyzed by immunoblotting. (B) Naive B cells from CD45.1 B1-8hi gene-targeted mice were transferred to C57BL/6 mice followed by immunization with NP-CGG in alum. Rapamycin (300 μg/kg) or PBS (control) were injected i.p. on day −1 and day 0. At 24 hr after Ag injection, phosphorylation status of S6 protein of immunized donor B cells and parental naive B cells was measured by intracellular flow cytometric analysis. The donor B cells of immunized mice or naive B cells from B1-8hi gene-targeted mice were collected by sorting and the amount of Bach2 mRNA was measured by qRT-PCR. (D) Purified C57BL/6 spleen B cells were prestimulated with CD40 antibody (2 μg/ml), IL-4 (10 ng/ml), and IgM antibody (1 μg/ml) for 1 day and infected with a mock or Foxo1-CA retrovirus. The infected cells were further cultured for 48 hr and infected GFP+ and noninfected GFP− cells were sorted. The amounts of Bach2 mRNA were measured by qRT-PCR. Bar graph represents the mean ± SD. The data were the representative of at least three independent experiments. ∗p < 0.05. See also Figure S6. Immunity 2013 39, 136-147DOI: (10.1016/j.immuni.2013.06.011) Copyright © 2013 Elsevier Inc. Terms and Conditions